-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A999184 | Anti-Tissue factor / CD142 Reference Antibody (Chugai patent anti-TF), Anti-Tissue factor / CD142 Reference Antibody (Chugai patent anti-TF), |
|||
| A999185 | Anti-Tissue factor / CD142 Reference Antibody (tisotumab), Anti-Tissue factor / CD142 Reference Antibody (tisotumab), |
|||
| A999186 | Anti-Tissue factor / CD142 Reference Antibody (TNX-832), Anti-Tissue factor / CD142 Reference Antibody (TNX-832), |
|||
| A999187 | Anti-TLR2 / CD282 Reference Antibody (tomaralimab), Anti-TLR2 / CD282 Reference Antibody (tomaralimab), |
|||
| A999188 | Anti-TLR3 / CD283 Reference Antibody (CNTO5429), Anti-TLR3 / CD283 Reference Antibody (CNTO5429), |
|||
| A999189 | Anti-TLR7 Reference Antibody (U.Tokyo patent anti-TLR7), Anti-TLR7 Reference Antibody (U.Tokyo patent anti-TLR7), |
|||
| A999190 | Anti-TMEFF1 / Tomoregulin-1 Reference Antibody (Bluefin patent anti-TMEFF1), Anti-TMEFF1 / Tomoregulin-1 Reference Antibody (Bluefin patent anti-TMEFF1), |
|||
| A999191 | Anti-TMEFF2 Reference Antibody (Janssen patent anti-TMEFF2), Anti-TMEFF2 Reference Antibody (Janssen patent anti-TMEFF2), |
|||
| A999192 | Anti-TMPRSS2 Reference Antibody (Regeneron patent anti-TMPRSS2 ), Anti-TMPRSS2 Reference Antibody (Regeneron patent anti-TMPRSS2 ), |
|||
| A999193 | Anti-TNFRSF10A / TRAILR1 / CD261 Reference Antibody (mapatumumab), Anti-TNFRSF10A / TRAILR1 / CD261 Reference Antibody (mapatumumab), |
|||
| A999194 | Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (benufutamab), Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (benufutamab), |
|||
| A999195 | Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (conatumumab), Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (conatumumab), |
|||
| A999196 | Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (drozitumab), Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (drozitumab), |
|||
| A999197 | Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (lexatumumab), Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (lexatumumab), |
|||
| A999198 | Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tigatuzumab), Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tigatuzumab), |
|||
| A999199 | Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tilogotamab), Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tilogotamab), |
|||
| A999200 | Anti-TNFRSF12A / TWEAKR / CD266 Reference Antibody (enavatuzumab), Anti-TNFRSF12A / TWEAKR / CD266 Reference Antibody (enavatuzumab), |
|||
| A999201 | Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab), Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab), |
|||
| A999202 | Anti-TNFRSF17 / BCMA / CD269 Reference Antibody (belantamab), Anti-TNFRSF17 / BCMA / CD269 Reference Antibody (belantamab), |
|||
| A999203 | Anti-TNFRSF18 / GITR / CD357 Reference Antibody (Korea Natl.Cancer Ctr. patent anti-GITR), Anti-TNFRSF18 / GITR / CD357 Reference Antibody (Korea Natl.Cancer Ctr. patent anti-GITR), |
